Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 24, Number 5—May 2018

Second Human Pegivirus in Hepatitis C Virus–Infected and Hepatitis C Virus/HIV-1–Co-infected Persons Who Inject Drugs, China

Haiying Wang1, Zhengwei Wan1, Qiang Sun1, Nalin Zhu, Tianyi Li, Xuqi Ren, Xiaoping An, Shuyun Deng, Yue Wu, Xiufen Li, Lin Li, Jingyun Li, Yigang Tong, and Shixing TangComments to Author 
Author affiliations: Southern Medical University, Guangzhou, China (H. Wang, Z. Wan, N. Zhu, Y. Wu, X. Li, S. Tang); Guangdong Provincial Key Laboratory of Tropical Disease Research, Guangzhou (H. Wang, Z. Wan, N. Zhu, Y. Wu, X. Li, S. Tang); Beijing Institute of Microbiology and Epidemiology, Beijing, China (Q. Sun, T. Li, X. An, L. Li, J. Li, Y. Tong); Guangdong Provincial Dermatology Hospital, Guangzhou (X. Ren); Nanfang Hospital, Guangzhou (S. Deng)

Main Article

Table 1

Detection frequencies of HPgV-2 in different populations in Guangdong and Sichuan Provinces, China*

Sichuan Province
HIV-1+/HCV Ab+ 270 43 (15.9) 8 (3.0) NT

*Ab, antibodies; HBV, hepatitis B virus; HCV, hepatitis C virus; HPgV, human pegivirus; HPgV-2, second human pegivirus; MSM, men who have sex with men; NT, not tested; PWID, people who inject drugs; +, positive; –, negative.

Main Article

1These authors contributed equally to this article.

Page created: April 17, 2018
Page updated: April 17, 2018
Page reviewed: April 17, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.